Open Clinical Trial of CBT-based Multiprofessional Rehabilitation for Exhaustion Disorder

Sponsor
Uppsala University (Other)
Overall Status
Unknown status
CT.gov ID
NCT03360136
Collaborator
PBM Sweden AB (Other)
400
2
1
38.9
200
5.1

Study Details

Study Description

Brief Summary

Stress-related mental disorders are today the leading cause of long-term sick leave in Sweden, and a large part of this increase is due to Clinical burnout, in Sweden called "Exhaustion disorder" (ED). Even though clinical guidelines recommend multi-professional rehabilitation (MPR) for ED, few studies have evaluated the effects of these treatment programs in clinical practice. This large-scale open clinical trial investigates whether MPR for ED seems to alleviate symptoms of ED and if it results in return-to-work.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Multi-professional CBT-rehabilitation
N/A

Detailed Description

This study is carried out at two specialized stress rehabilitation centers in Stockholm. All patients included in the clinics stress rehabilitation program are asked to participate in the study and are recruited consecutively from October 2017 throughout December 2018. An estimate of 400 patients will be included. The treatment program is a 24-week Multiprofessional standardized CBT-rehabilitation consisting of a nine-session CBT group treatment (stress management) followed by a seven-session group treatment in applied relaxation. Parallel to the group treatments patients receives nine sessions of individual CBT, three visits to an MD (for medication, follow-up, and sick-listing), two individual sessions to a physiotherapist and a three session-exercise group. Also, vocational measures are taken through rehabilitation meetings together with the patient's employer (if an employer exists). Primary treatment outcomes will be return-to-work (RTW) and symptoms of ED, anxiety, and depression. Secondary treatment outcomes will be quality of life, pathological worry, psychological flexibility, clinical perfectionism, insomnia, burnout, and symptoms. Predictors of symptom development and RTW will be explored. Also, comorbidity of chronic pain, negative effects of psychotherapy and treatment credibility will be investigated.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
400 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Open Clinical TrialOpen Clinical Trial
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Multiprofessional Rehabilitation for Exhaustion Disorder
Actual Study Start Date :
Oct 1, 2017
Anticipated Primary Completion Date :
Dec 29, 2020
Anticipated Study Completion Date :
Dec 29, 2020

Arms and Interventions

Arm Intervention/Treatment
Other: Multi-professional CBT-rehabilitation

24 weeks CBT-based multi-professional rehabilitation.

Behavioral: Multi-professional CBT-rehabilitation
See "Detailed description"

Outcome Measures

Primary Outcome Measures

  1. Change from baseline in exhaustion symptoms [Week 12 and 24]

    Self-reported change in Karolinska Exhaustion Disorder Scale, 9 items

  2. Change from baseline to follow-up in exhaustion symptoms [Week 12, 24 and 76]

    Self-reported change in Karolinska Exhaustion Disorder Scale, 9 items

  3. Change from baseline in depression [Week 12 and 24]

    Self-reported change in Hospital Anxiety Depressin Scale (HADS), 14 items

  4. Change from baseline to follow-up in depression [Week 12, 24 and 76]

    Self-reported change in Hospital Anxiety Depressin Scale (HADS), 14 items

  5. Change from baseline in anxiety [Week 12 and 24]

    Self-reported change in Hospital Anxiety Depressin Scale (HADS), 14 items

  6. Change from baseline to follow-up in anxiety [Week 12, 24 and 76]

    Self-reported change in Hospital Anxiety Depressin Scale (HADS), 14 items

  7. Change from baseline in employment rate [Week 24]

    Sick-leave data collected from the Swedish Social Insurance Agency

  8. Change from baseline to follow-up in employment rate [Week 24 and 76]

    Sick-leave data collected from the Swedish Social Insurance Agency

Secondary Outcome Measures

  1. Change from baseline in Quality of life [Week 24]

    Self-reported change in EQ5D, 5 items

  2. Change from baseline to follow-up in Quality of life [Week 24 and 76]

    Self-reported change in EQ5D, 5 items

  3. Change from baseline in insomnia symptoms [Week 12 and 24]

    Self-reported change in Insomnia Severity Index (ISI), 7 items

  4. Change from baseline to follow-up in insomnia symptoms [Week 12, 24 and 76]

    Self-reported change in Insomnia Severity Index (ISI), 7 items

  5. Change from baseline in Clinical Perfectionism [Week 12 and 24]

    Self-reported change in Clinical Perfectionism Questionnaire (CPQ), 12 items

  6. Change from baseline to follow-up in Clinical Perfectionism [Week 12, 24 and 76]

    Self-reported change in Clinical Perfectionism Questionnaire (CPQ), 12 items

  7. Change from baseline in Psychological Flexibility [Week 12 and 24]

    Self-reported change in the Swedish Acceptance and Action Questionnaire (SAAQ), 6 items

  8. Change from baseline to follow-up in Psychological Flexibility [Week 12, 24 and 76]

    Self-reported change in the Swedish Acceptance and Action Questionnaire (SAAQ), 6 items

  9. Change from baseline in pathological worry [Week 12 and 24]

    Self reported change in Penn State Worry Questionnaire ultra-brief (PSWQ-brief), 3 items

  10. Change from baseline to follow-up in pathological worry [Week 12, 24 and 76]

    Self reported change in Penn State Worry Questionnaire ultra-brief (PSWQ-brief), 3 items

  11. Change from baseline in perceived work ability [Week 12 and 24]

    Self-rated work ability, 1 single item from Work Ability index (WAI)

  12. Change from baseline to follow up in perceived work ability [Week 12, 24 and 76]

    Self-rated work ability, 1 single item from Work Ability index (WAI)

  13. Change from baseline in burnout [Week 12 and 24]

    Self-rated burnout in Shirom Melamed Burnout Questionnaire (SMBQ), 22 items

  14. Change from baseline to follow-up in burnout [Week 12, 24 and 76]

    Self-rated burnout in Shirom Melamed Burnout Questionnaire (SMBQ), 22 items

Other Outcome Measures

  1. Negative Effects of psychotherapy [at 24 week only]

    Self-Reported negative effects in Negative Effects Questionnaire, 32 items

  2. Treatment credibility rating [Baseline and at 12 weeks]

    Self-reported treatment credibility, treatment Credibility Scale (TCS), 5 items

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 64 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Confirmed exhaustion disorder according to criteria established by the Swedish National Board of Health and Welfare

  • 18 - 64 years of age

  • Considered suitable for multimodal rehabilitation in group

  • Self-rating of > 4,5 pĂ„ SMBQ

Exclusion Criteria:
  • Abuse of alcohol or drugs

  • Moderate-high suicidal risk

  • Severe psychiatric illness (severe depression, bipolar, schizophrenia etc.)

  • Untreated PTSD

Contacts and Locations

Locations

Site City State Country Postal Code
1 PBM Sweden AB Globen Stockholm Södermanland Sweden 12177
2 PBM Sweden City Stockholm Uppland Sweden 114 47

Sponsors and Collaborators

  • Uppsala University
  • PBM Sweden AB

Investigators

  • Study Chair: Gunilla Brodda Jansen, Assoc. Proff., Karolinska University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Uppsala University
ClinicalTrials.gov Identifier:
NCT03360136
Other Study ID Numbers:
  • 2016/1834- 31/2
First Posted:
Dec 2, 2017
Last Update Posted:
Apr 29, 2020
Last Verified:
Apr 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Uppsala University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 29, 2020